|
| Gilead shares surged higher this morning after the biotech announced positive preliminary results for its remdesivir in the treatment of patients with COVID-19. The trial showed at least 50% of the 397 patients treated with a 5-day dosage of the antiviral drug improved, with more than half discharged from the hospital within two weeks. “The study demonstrates the potential for some patients to be... |
| iBio Inc (OTC: IBIO): iBio shares jumped as much as 65% yesterday after it gave an update on its COVID-19 vaccine manufacturing capacity. “If our own proprietary SARS-CoV-2 Virus-Like Particle (“VLP”) program, IBIO-200, results in an approved vaccine, we estimate that we could make about 500 million doses of high-quality product annually at our Texas facility, depending upon ... |
ADM looks poised to reverse a long-term downward trend – is it a great value, or a value trap?All of these measures seem to be giving investors hope that, while the threat of infection from COVID-19 remains, we might be able to find a balance between managing the health crisis and keeping the economy going. If that’s the case, then some of the areas that have seen the biggest drops in economic stability in the last month or so – unemployment and therefore consumer confidence, in particular – could start to see material improvements. Read More |
| |
|
|
Featured StockJernigan Capital, Inc. (JCAP) – Buy Price: $14.30 or betterJernigan Capital is a New York Stock Exchange-listed real estate investment trust (NYSE: JCAP) that provides debt and equity capital to private developers, owners and operators of self-storage facilities with a view to eventual outright ownership of facilities we finance. Our mission is to maximize shareholder value by accumulating a multi-billion dollar investment portfolio consisting of the newest, most attractive and best located self-storage facilities in the United States through a talen... |
Other Top Stories |
| |
Trend Following PicksAll Picks |
Reversal PicksAll Picks |
Already subscribed to our premium service?Click here to Login.Not a TradersPro subscriber yet?Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits |
This email was sent to its028@gmail.com by Investiv, LLC
Forward to a friend | Unsubscribe or Mange which emails you get from TradersPro
Investing is Inherently Risky
There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.
Hypothetical Results Are Reported
Results and examples used in the Company's advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage.
The Company's simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading.
Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company's software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Offers Disinterested Commentary and Analysis
The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one's own recommendations.
The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company's principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase.
Disclaimers, Terms & Conditions | Privacy Policy
Copyright © 2019
没有评论:
发表评论